Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships
Louise C. Druedahl, Timo Minssen, W. Nicholson Price
Vaccine (2021) Vol. 39, Iss. 42, pp. 6291-6295
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives
Eliana B. Souto, Cristina Blanco-Llamero, Karolline Krambeck, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 1-17
Open Access | Times Cited: 33
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
Zhe Cheng, Huichao Huang, Mingru Yin, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions
Elize Massard da Fonseca, Kenneth C. Shadlen, Helena de Moraes Achcar
Research Policy (2023) Vol. 52, Iss. 4, pp. 104739-104739
Open Access | Times Cited: 39
The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102295-102295
Open Access | Times Cited: 8
Voices of Nanomedicine: Blueprint Guidelines for Collaboration in Addressing Global Unmet Medical Needs
Rajendra Prasad, Arnab Ghosh, Vinay Patel, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
A critical review of public–private partnerships in the COVID-19 pandemic: key themes and future research agenda
Isaac Akomea-Frimpong, Xiaohua Jin, Robert Osei‐Kyei, et al.
Smart and Sustainable Built Environment (2022) Vol. 12, Iss. 4, pp. 701-720
Closed Access | Times Cited: 34
STEM education in the Global North and Global South: competition, conformity, and convenient collaborations
Ronicka Mudaly, Tamirirofa Chirikure
Frontiers in Education (2023) Vol. 8
Open Access | Times Cited: 16
Standing the test of COVID-19: charting the new frontiers of medicine
Simon Cauchemez, Giulio Cossu, Nathalie M. Delzenne, et al.
Frontiers in Science (2024) Vol. 2
Open Access | Times Cited: 6
Influence of the COVID-19 pandemic on climate change summit negotiations from the climate governance perspective
P. Vo, Huu Hao Ngo, Wenshan Guo, et al.
The Science of The Total Environment (2023) Vol. 878, pp. 162936-162936
Open Access | Times Cited: 14
‘God protects us from death through faith and science’: a qualitative study on the role of faith leaders in combating the COVID-19 pandemic and in building COVID-19 vaccine trust in Addis Ababa, Ethiopia
Kalkidan Yibeltal, Firehiwot Workneh, Hanna Melesse, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e071566-e071566
Open Access | Times Cited: 5
Unlocking disease insights to facilitate drug development: Pharmaceutical industry–academia collaborations in inflammation and immunology
Elena Peeva, Emma Guttman‐Yassky, Yuji Yamaguchi, et al.
Drug Discovery Today (2025), pp. 104317-104317
Closed Access
Intellectual Property Management in Open Innovation
P. Selvakumar, Pallavi S. Deshpande, V. Karthick, et al.
IGI Global eBooks (2025), pp. 227-254
Closed Access
Enhancing University-Enterprise Collaborations: A Framework for Disaster Resilience in Asia
Kinkini Hemachandra, U. T. G. Perera, Dilanthi Amaratunga, et al.
(2025), pp. 397-418
Closed Access
Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review
Li Ping Wong, Hai Yen Lee, Haridah Alias, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Optimizing emergency response systems in urban health crises: A project management approach to public health preparedness and response
Tom Ongesa, Okechukwu Paul-Chima Ugwu, Chinyere N. Ugwu, et al.
Medicine (2025) Vol. 104, Iss. 3, pp. e41279-e41279
Open Access
Host-targeted antivirals against SARS-CoV-2 in clinical development - prospect or disappointment?
André Schreiber, Stephan Ludwig
Antiviral Research (2025) Vol. 235, pp. 106101-106101
Open Access
Rethinking global health research for better methods, processes, and capacity: global evidence and perspectives from the Global Health Network Conference 2022
Malak Alrubaie, Mohammed Alkhaldi, Zeeshan Salvia, et al.
Global Health Journal (2025)
Open Access
The Vaccine World of COVID-19: India’s Contribution
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1943-1943
Open Access | Times Cited: 18
Teamwork and Collaboration: Bright Spots of Governmental Public Health Employee Reflections on the COVID-19 Response
Emilie R. Madsen, Kay Schaffer, Rachel Hare Bork, et al.
Journal of Public Health Management and Practice (2024) Vol. 30, Iss. 3, pp. 377-383
Open Access | Times Cited: 3
Challenges of biomedical research collaboration in India: Perceptions of Indian and international researchers
Vaishali Deshmukh, Tanuja Agarwala, Archisman Mohapatra, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0305159-e0305159
Open Access | Times Cited: 3
Grey models for data analysis and decision-making in uncertainty during pandemics
R. Rajesh
International Journal of Disaster Risk Reduction (2024), pp. 104881-104881
Closed Access | Times Cited: 3
A patent-based analysis of the evolution of basic, mission-oriented, and applied research in European universities
Gabriele Angori, Chiara Marzocchi, Laura Ramaciotti, et al.
The Journal of Technology Transfer (2023) Vol. 49, Iss. 2, pp. 609-641
Open Access | Times Cited: 8
The impact of COVID-19 on clinical research at Australian and New Zealand universities: A qualitative study
Renu Bhutkar, Sarira El‐Den, Claire L. O’Reilly, et al.
Collegian Journal of the Royal College of Nursing Australia (2023) Vol. 30, Iss. 4, pp. 612-619
Open Access | Times Cited: 8
Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases
Wenhui Mao, Armand Zimmerman, Elina Urli Hodges, et al.
BMJ Global Health (2023) Vol. 8, Iss. 9, pp. e012855-e012855
Open Access | Times Cited: 8
Understanding immunity to influenza: implications for future vaccine development
Ralph A. Tripp
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 871-875
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top